Literature DB >> 25444593

Cellular and molecular changes to cortical neurons following low intensity repetitive magnetic stimulation at different frequencies.

Stephanie Grehl1, Helena M Viola2, Paula I Fuller-Carter3, Kim W Carter4, Sarah A Dunlop3, Livia C Hool2, Rachel M Sherrard5, Jennifer Rodger6.   

Abstract

BACKGROUND: Repetitive transcranial magnetic stimulation is increasingly used as a treatment for neurological dysfunction. Therapeutic effects have been reported for low intensity rTMS (LI-rTMS) although these remain poorly understood.
OBJECTIVE: Our study describes for the first time a systematic comparison of the cellular and molecular changes in neurons in vitro induced by low intensity magnetic stimulation at different frequencies.
METHODS: We applied 5 different low intensity repetitive magnetic stimulation (LI-rMS) protocols to neuron-enriched primary cortical cultures for 4 days and assessed survival, and morphological and biochemical change.
RESULTS: We show pattern-specific effects of LI-rMS: simple frequency pulse trains (10 Hz and 100 Hz) impaired cell survival, while more complex stimulation patterns (theta-burst and a biomimetic frequency) did not. Moreover, only 1 Hz stimulation modified neuronal morphology, inhibiting neurite outgrowth. To understand mechanisms underlying these differential effects, we measured intracellular calcium concentration during LI-rMS and subsequent changes in gene expression. All LI-rMS frequencies increased intracellular calcium, but rather than influx from the extracellular milieu typical of depolarization, all frequencies induced calcium release from neuronal intracellular stores. Furthermore, we observed pattern-specific changes in expression of genes related to apoptosis and neurite outgrowth, consistent with our morphological data on cell survival and neurite branching.
CONCLUSIONS: Thus, in addition to the known effects on cortical excitability and synaptic plasticity, our data demonstrate that LI-rMS can change the survival and structural complexity of neurons. These findings provide a cellular and molecular framework for understanding what low intensity magnetic stimulation may contribute to human rTMS outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium signaling; Cortical neurons; Pulsed magnetic fields; Repetitive transcranial magnetic stimulation; rTMS

Mesh:

Substances:

Year:  2014        PMID: 25444593     DOI: 10.1016/j.brs.2014.09.012

Source DB:  PubMed          Journal:  Brain Stimul        ISSN: 1876-4754            Impact factor:   8.955


  36 in total

1.  Pediatric Neuromodulation Comes of Age.

Authors:  Paul E Croarkin; Alexander Rotenberg
Journal:  J Child Adolesc Psychopharmacol       Date:  2016-09-07       Impact factor: 2.576

Review 2.  What does low-intensity rTMS do to the cerebellum?

Authors:  N Morellini; S Grehl; A Tang; J Rodger; J Mariani; A M Lohof; R M Sherrard
Journal:  Cerebellum       Date:  2015-02       Impact factor: 3.847

3.  Repetitive transcranial magnetic stimulation inhibits Sirt1/MAO-A signaling in the prefrontal cortex in a rat model of depression and cortex-derived astrocytes.

Authors:  Zheng-Wu Peng; Fen Xue; Cui-Hong Zhou; Rui-Guo Zhang; Ying Wang; Ling Liu; Han-Fei Sang; Hua-Ning Wang; Qing-Rong Tan
Journal:  Mol Cell Biochem       Date:  2017-09-25       Impact factor: 3.396

Review 4.  The neuronal stimulation-transcription coupling map.

Authors:  Kelsey M Tyssowski; Jesse M Gray
Journal:  Curr Opin Neurobiol       Date:  2019-06-01       Impact factor: 6.627

5.  A Preclinical Study of Standard Versus Accelerated Transcranial Magnetic Stimulation for Depression in Adolescents.

Authors:  Bhedita J Seewoo; Lauren A Hennessy; Liz A Jaeschke; Leah A Mackie; Sarah J Etherington; Sarah A Dunlop; Paul E Croarkin; Jennifer Rodger
Journal:  J Child Adolesc Psychopharmacol       Date:  2021-12-31       Impact factor: 3.031

Review 6.  Epigenome Interactions with Patterned Neuronal Activity.

Authors:  Jillian Belgrad; R Douglas Fields
Journal:  Neuroscientist       Date:  2018-02-27       Impact factor: 7.519

7.  Moving back in the brain to drive the field forward: Targeting neurostimulation to different brain regions in animal models of depression and neurodegeneration.

Authors:  Michelle R Madore; Eugenia Poh; Samuel John Bollard; Jesus Rivera; Joy Taylor; Jauhtai Cheng; Eric Booth; Monica Nable; Alesha Heath; Jerry Yesavage; Jennifer Rodger; M Windy McNerney
Journal:  J Neurosci Methods       Date:  2021-06-17       Impact factor: 2.987

8.  Low intensity repetitive transcranial magnetic stimulation does not induce cell survival or regeneration in a mouse optic nerve crush model.

Authors:  Alexander D Tang; Kalina Makowiecki; Carole Bartlett; Jennifer Rodger
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 9.  Corticospinal Motor Circuit Plasticity After Spinal Cord Injury: Harnessing Neuroplasticity to Improve Functional Outcomes.

Authors:  Syed Faraz Kazim; Christian A Bowers; Chad D Cole; Samantha Varela; Zafar Karimov; Erick Martinez; Jonathan V Ogulnick; Meic H Schmidt
Journal:  Mol Neurobiol       Date:  2021-08-03       Impact factor: 5.590

Review 10.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.